“我们的发现为证明类风湿关节炎为何在阿尔茨海默症中扮演负风险因子提供了一个有强有力的解释，”他说。
"Our findings provide a compelling explanation for why rheumatoid arthritis is a negative risk factor for Alzheimer's disease," he said.
能使促炎细胞因子失活的新型生物制剂也已应用于类风湿关节炎的治疗。
Newer biological agents that work by inactivation of proinflammatory cytokines are available for treatment of RA.
目的探讨环瓜氨酸多肽(CCP)抗体、抗角蛋白抗体(aka)、类风湿因子(RF)和抗ra33抗体对类风湿性关节炎(RA)的临床应用价值。
Objective to approach the value of anti-cyclic citrullinated peptide antibody (CCP), Anti-keratin antibody (AKA), anti-RA33 and rheumatoid factor (RF) in the diagnosis of rheumatoid arthritis (ra).
应用推荐